110 related articles for article (PubMed ID: 2627615)
1. Serum neopterin in patients receiving bone marrow transplant.
Pavletić Z; Labar B; Bogdanić V; Nemet D; Mrsić M; Stavljenić A; Cvoriscec D; Presecki V; Petrovecki M
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():97-8. PubMed ID: 2627615
[No Abstract] [Full Text] [Related]
2. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
[TBL] [Abstract][Full Text] [Related]
3. Urinary neopterin in bone marrow recipients.
Volin L; Jansson SE; Turpeinen U; Pomoell UM; Ruutu T
Transplant Proc; 1987 Feb; 19(1 Pt 3):2651-4. PubMed ID: 3029922
[No Abstract] [Full Text] [Related]
4. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation.
Weiss G; Schwaighofer H; Herold M; Nachbaur D; Wachter H; Niederwieser D; Werner ER
Transplantation; 1995 Dec; 60(11):1239-44. PubMed ID: 8525517
[TBL] [Abstract][Full Text] [Related]
5. [Neopterin determination in the screening for spongiosa donors].
Peters KM; Leusch HG; Bruchhausen B; Schilgen M; Markos-Pusztai S
Z Orthop Ihre Grenzgeb; 1990; 128(5):453-6. PubMed ID: 2147332
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
[No Abstract] [Full Text] [Related]
7. Plasma neopterin as an adjunct to C-reactive protein in assessment of infection.
Sheldon J; Riches PG; Soni N; Jurges E; Gore M; Dadian G; Hobbs JR
Clin Chem; 1991 Dec; 37(12):2038-42. PubMed ID: 1764778
[TBL] [Abstract][Full Text] [Related]
8. Neopterin: an useful biochemical marker in the monitoring of allogeneic bone marrow transplantation.
Bron D; Wouters A; Barekayo I; Snoeck R; Stryckmans P; Fruhling P
Acta Clin Belg; 1988; 43(2):120-6. PubMed ID: 3041718
[No Abstract] [Full Text] [Related]
9. Neopterin changes after clinical heart transplantation.
Wang SS; Chu SH; Ko WJ
Transplant Proc; 1996 Jun; 28(3):1730-2. PubMed ID: 8658860
[No Abstract] [Full Text] [Related]
10. [Serum neopterin in hemorrhagic vasculitis].
Baranov AA; Samsonov MI; Nasonov EL; Vachter H; Shilkina NP; Fuchs D; Salozhin KV
Klin Med (Mosk); 1997; 75(6):34-6. PubMed ID: 9273397
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
Kapoor N; Copelan EA; Klein J; Tutschka PJ
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
[No Abstract] [Full Text] [Related]
12. Monitoring of the serum neopterin/creatinine ratio in renal transplantation.
Hacini D; Guerin C; Berthoux P; Ville G; Berthoux F
Transplant Proc; 1987 Feb; 19(1 Pt 3):2185-6. PubMed ID: 3274488
[No Abstract] [Full Text] [Related]
13. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
15. [Predictive value of neopterin in boutonneuse fever].
Soriano V; Sabriá M; Davins J; Farré J; Aramburu J; Manterola JM; Rey-Joly C
Rev Clin Esp; 1989 Nov; 185(8):396-8. PubMed ID: 2623265
[TBL] [Abstract][Full Text] [Related]
16. Neopterin: a biochemical marker in the process of organ transplantation.
Zachariah NY; Nikaein A; Gonwa T; Alivazatos P; Klintmalm G; Husberg B
Transplant Proc; 1989 Feb; 21(1 Pt 2):2294-6. PubMed ID: 2652742
[No Abstract] [Full Text] [Related]
17. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
18. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
[No Abstract] [Full Text] [Related]
19. Early complications of bone marrow transplantation in children and adults.
Tutschka PJ
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():22-6. PubMed ID: 2516755
[No Abstract] [Full Text] [Related]
20. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
